Sherlock Biosciences CRISPR SARS-CoV-2 Diagnostic Test Gets FDA Emergency Use Authorization

May 07, 2020

|

NEW YORK – Genetic engineering company Sherlock Biosciences said on Thursday that it has received Emergency Use Authorization from the US Food and Drug Administration for its Sherlock CRISPR SARS-CoV-2 kit for the detection of the virus that causes COVID-19.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Officially Notified

The US has sent its formal notice of withdrawal from the World Health Organization, according to the Wall Street Journal.

Starting With Bit of a Raise

Science reports that a draft spending bill would increase the US National Institutes of Health budget by 13 percent.

Harvard, MIT File Lawsuit Against Trump Administration

The Harvard Crimson reports that Harvard and MIT are suing the Department of Homeland Security and ICE over the new international student visa policy.

Nucleic Acids Research Studies on Molecular Typing, RNA-DNA Hybrids, Protein-RNA Binding Tools

In Nucleic Acids Research this week: algorithm to determine molecular sequence types and other microbial features, computational method to uncover R-loop structures, and more.

Menu

Sherlock Biosciences CRISPR SARS-CoV-2 Diagnostic Test Gets FDA Emergency Use Authorization

To read the full story....

Breaking News

Payor Policy Study Reveals Progress, Challenges in Liquid Biopsy Reimbursement

Bacterial Toxin Leads to CRISPR-Free Mitochondrial DNA Base Editing

Native Americans, Polynesians in Contact 800 Years Ago, Genomic Study Indicates

Glioblastoma, Developing Brain Cell Populations Show Similarities in Single-Cell RNA-Seq Study

Twist Bioscience, Takeda Pharma Partner to Develop Antibodies for Oncology, Rare Diseases

WuXi NextCode, Olink Ink Agreement to Provide Proteomic Assays in China

The Scan

Officially Notified

Starting With Bit of a Raise

Harvard, MIT File Lawsuit Against Trump Administration

Nucleic Acids Research Studies on Molecular Typing, RNA-DNA Hybrids, Protein-RNA Binding Tools

What's Popular?

Guardant Health to Develop Liquid Biopsy Companion Diagnostic for Janssen NSCLC Therapy

GenMark Diagnostics Preliminary Q2 Revenues Rise 118 Percent on SARS-CoV-2 Tests

Progenity Asks Court to Declare Non-Infringement of Natera Patents

Twist Bioscience, Takeda Pharma Partner to Develop Antibodies for Oncology, Rare Diseases

Luminex Preliminary Q2 Revenues Rise More Than 30 Percent on Pandemic-Related Sales

Sponsorships